Loading provider…
Loading provider…
Nephrology Physician in Pensacola, FL
NPI: 1336141555Primary Practice Location
Azura Surgery Center Renalus Pensacola
1619 Creighton Rd, Pensacola, FL
Primary Employer
Renalus Center for Kidney Care
renalus.com
HQ Phone
Get M.D. Mark's Phone Numberphone_androidMobile
Get M.D. Mark's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardME State Medical License
FL State Medical License
AL State Medical License
FL State Medical License
2018 - 2026
AL State Medical License
2000 - 2025
ME State Medical License
1998 - 2021
NC State Medical License
2000 - 2016

American Board of Internal Medicine
Internal Medicine

American Board of Internal Medicine
Nephrology
The Warren Alpert Medical School of Brown University
medical.brown.edu
Medical School
Until 1996
Maine Medical Center
Fellowship • Nephrology
1999 - 2001
MaineHealth
Residency • Internal Medicine
1996 - 1999
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 352 | 550 |
| 2 | 99232Subsequent hospital inpatient care, typically 25 minutes per day | 292 | 818 |
| 3 | 99223Initial hospital inpatient care, typically 70 minutes per day | 114 | 119 |
| 4 | 99222Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 68 | 71 |
| 5 | 90935Hemodialysis procedure with one physician evaluation | 64 | 125 |
Authors: Chodobski, A, Szmydynger-Chodobska, J, Vannorsdall, M D, Epstein, M H, Johanson, C E
Journal: Regul Pept
Authors: Vannorsdall, Mark D, Hariachar, Srinivas, Hewitt, L Arthur
Journal: Postgrad Med
Authors: Vannorsdall, M D, Thomas, S, Smith, R P, Zimmerman, R, Christman, R, Vella, J P
Journal: Transpl Infect Dis
Lead Sponsor: Eli Lilly and Company
Intervention / Treatment: DRUG: Dulaglutide, DRUG: Insulin lispro, DRUG: Insulin glargine